Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2006 |
Outros Autores: | , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Sociedade Brasileira de Medicina Tropical |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000100003 |
Resumo: | The first choice of treatment for American cutaneous leishmaniasis is the pentavalent antimonial drug. Although it has been shown that this treatment is mostly effective and indicated, some disadvantages should be taken into account such as side effects, long term treatment inconveniences and counter-indication for patients suffering from cardiopathy, nephropathy; yet, aging, pregnancy and other conditions. With the advent of the vaccine anti-American cutaneous leishmaniasis as a prophylactic measure, studies on therapy using the vaccine associated or not with other drugs have been performed by many investigators and it is currently among the alternative treatments and prevention measures for American cutaneous leishmaniasis. In conclusion, the association between antimony and vaccine (immunochemotherapy) showed the same cure rate when compared with the standard treatment (100%) and it was also able to reduce the salt volume in 17.9% and treatment length from 87 to 62 days, decreasing side effects. |
id |
SBMT-1_c55001f889befad76aaea481ee12c5ca |
---|---|
oai_identifier_str |
oai:scielo:S0037-86822006000100003 |
network_acronym_str |
SBMT-1 |
network_name_str |
Revista da Sociedade Brasileira de Medicina Tropical |
repository_id_str |
|
spelling |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatmentAmerican cutaneous leishmaniasisTreatmentImmunotherapyThe first choice of treatment for American cutaneous leishmaniasis is the pentavalent antimonial drug. Although it has been shown that this treatment is mostly effective and indicated, some disadvantages should be taken into account such as side effects, long term treatment inconveniences and counter-indication for patients suffering from cardiopathy, nephropathy; yet, aging, pregnancy and other conditions. With the advent of the vaccine anti-American cutaneous leishmaniasis as a prophylactic measure, studies on therapy using the vaccine associated or not with other drugs have been performed by many investigators and it is currently among the alternative treatments and prevention measures for American cutaneous leishmaniasis. In conclusion, the association between antimony and vaccine (immunochemotherapy) showed the same cure rate when compared with the standard treatment (100%) and it was also able to reduce the salt volume in 17.9% and treatment length from 87 to 62 days, decreasing side effects.Sociedade Brasileira de Medicina Tropical - SBMT2006-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000100003Revista da Sociedade Brasileira de Medicina Tropical v.39 n.1 2006reponame:Revista da Sociedade Brasileira de Medicina Tropicalinstname:Sociedade Brasileira de Medicina Tropical (SBMT)instacron:SBMT10.1590/S0037-86822006000100003info:eu-repo/semantics/openAccessMayrink,WilsonBotelho,Ana Cristina de CarvalhoMagalhães,Paulo AraújoBatista,Sebastião MarianoLima,Antonio de OliveiraGenaro,OdairCosta,Carlos Alberto daMelo,Maria Norma deMichalick,Marilene Susan MarquesWilliams,PaulDias,MagnoCaiaffa,Waleska TeixeiraNascimento,Evaldo doMachado-Coelho,George Luiz Linseng2006-02-23T00:00:00Zoai:scielo:S0037-86822006000100003Revistahttps://www.sbmt.org.br/portal/revista/ONGhttps://old.scielo.br/oai/scielo-oai.php||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br1678-98490037-8682opendoar:2006-02-23T00:00Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)false |
dc.title.none.fl_str_mv |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment |
title |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment |
spellingShingle |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment Mayrink,Wilson American cutaneous leishmaniasis Treatment Immunotherapy |
title_short |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment |
title_full |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment |
title_fullStr |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment |
title_full_unstemmed |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment |
title_sort |
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment |
author |
Mayrink,Wilson |
author_facet |
Mayrink,Wilson Botelho,Ana Cristina de Carvalho Magalhães,Paulo Araújo Batista,Sebastião Mariano Lima,Antonio de Oliveira Genaro,Odair Costa,Carlos Alberto da Melo,Maria Norma de Michalick,Marilene Susan Marques Williams,Paul Dias,Magno Caiaffa,Waleska Teixeira Nascimento,Evaldo do Machado-Coelho,George Luiz Lins |
author_role |
author |
author2 |
Botelho,Ana Cristina de Carvalho Magalhães,Paulo Araújo Batista,Sebastião Mariano Lima,Antonio de Oliveira Genaro,Odair Costa,Carlos Alberto da Melo,Maria Norma de Michalick,Marilene Susan Marques Williams,Paul Dias,Magno Caiaffa,Waleska Teixeira Nascimento,Evaldo do Machado-Coelho,George Luiz Lins |
author2_role |
author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Mayrink,Wilson Botelho,Ana Cristina de Carvalho Magalhães,Paulo Araújo Batista,Sebastião Mariano Lima,Antonio de Oliveira Genaro,Odair Costa,Carlos Alberto da Melo,Maria Norma de Michalick,Marilene Susan Marques Williams,Paul Dias,Magno Caiaffa,Waleska Teixeira Nascimento,Evaldo do Machado-Coelho,George Luiz Lins |
dc.subject.por.fl_str_mv |
American cutaneous leishmaniasis Treatment Immunotherapy |
topic |
American cutaneous leishmaniasis Treatment Immunotherapy |
description |
The first choice of treatment for American cutaneous leishmaniasis is the pentavalent antimonial drug. Although it has been shown that this treatment is mostly effective and indicated, some disadvantages should be taken into account such as side effects, long term treatment inconveniences and counter-indication for patients suffering from cardiopathy, nephropathy; yet, aging, pregnancy and other conditions. With the advent of the vaccine anti-American cutaneous leishmaniasis as a prophylactic measure, studies on therapy using the vaccine associated or not with other drugs have been performed by many investigators and it is currently among the alternative treatments and prevention measures for American cutaneous leishmaniasis. In conclusion, the association between antimony and vaccine (immunochemotherapy) showed the same cure rate when compared with the standard treatment (100%) and it was also able to reduce the salt volume in 17.9% and treatment length from 87 to 62 days, decreasing side effects. |
publishDate |
2006 |
dc.date.none.fl_str_mv |
2006-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000100003 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000100003 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0037-86822006000100003 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Medicina Tropical - SBMT |
publisher.none.fl_str_mv |
Sociedade Brasileira de Medicina Tropical - SBMT |
dc.source.none.fl_str_mv |
Revista da Sociedade Brasileira de Medicina Tropical v.39 n.1 2006 reponame:Revista da Sociedade Brasileira de Medicina Tropical instname:Sociedade Brasileira de Medicina Tropical (SBMT) instacron:SBMT |
instname_str |
Sociedade Brasileira de Medicina Tropical (SBMT) |
instacron_str |
SBMT |
institution |
SBMT |
reponame_str |
Revista da Sociedade Brasileira de Medicina Tropical |
collection |
Revista da Sociedade Brasileira de Medicina Tropical |
repository.name.fl_str_mv |
Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT) |
repository.mail.fl_str_mv |
||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br |
_version_ |
1752122153266839552 |